The article discusses the genetics and pathogenesis of inflammatory bowel disease (IBD), highlighting the role of genetic variants in disease development. Over 160 susceptibility loci have been identified through genome-wide association studies (GWAS), with many common variants contributing to IBD risk. However, these variants typically have modest effects, while rare variants, often found in specific populations, are more likely to be causative. Genetic studies have revealed that mutations in genes such as NADPH oxidase, TTC7A, XIAP, and IL-10 receptors are associated with IBD, particularly in severe early-onset cases. These findings have implications for clinical management, including targeted therapies and genetic counseling. The article also explores the overlap between IBD genetics and other diseases, such as leprosy and mycobacterial infections, and the role of environmental factors in disease development. Environmental triggers, including diet, smoking, and antibiotics, are important in IBD pathogenesis, with variations in these factors influencing disease risk. The study of microbiota in IBD patients has shown that gut microbiome composition is altered in IBD, with certain bacterial species associated with disease severity. The article also discusses the use of animal models and next-generation genetic tools to better understand IBD mechanisms. Overall, the integration of genetic and environmental factors is crucial for understanding IBD pathogenesis and developing effective treatments.The article discusses the genetics and pathogenesis of inflammatory bowel disease (IBD), highlighting the role of genetic variants in disease development. Over 160 susceptibility loci have been identified through genome-wide association studies (GWAS), with many common variants contributing to IBD risk. However, these variants typically have modest effects, while rare variants, often found in specific populations, are more likely to be causative. Genetic studies have revealed that mutations in genes such as NADPH oxidase, TTC7A, XIAP, and IL-10 receptors are associated with IBD, particularly in severe early-onset cases. These findings have implications for clinical management, including targeted therapies and genetic counseling. The article also explores the overlap between IBD genetics and other diseases, such as leprosy and mycobacterial infections, and the role of environmental factors in disease development. Environmental triggers, including diet, smoking, and antibiotics, are important in IBD pathogenesis, with variations in these factors influencing disease risk. The study of microbiota in IBD patients has shown that gut microbiome composition is altered in IBD, with certain bacterial species associated with disease severity. The article also discusses the use of animal models and next-generation genetic tools to better understand IBD mechanisms. Overall, the integration of genetic and environmental factors is crucial for understanding IBD pathogenesis and developing effective treatments.